tiprankstipranks
Abivax SA (DE:2X1)
XETRA:2X1
Germany Market
2X1
Abivax SA
RESEARCH TOOLSreports

Abivax SA (2X1) Stock News & Sentiment

4 Followers
Premium
Pre-Earnings
0RA9 Earnings Report this Week: Is It a Buy, Ahead of Earnings?
11d ago
Buy Rating Underpinned by Obefazimod’s Differentiated IBD Profile, Oral Convenience, and Upcoming ABTECT & ENHANCE-CD Data Catalysts
Premium
Ratings
Buy Rating Underpinned by Obefazimod’s Differentiated IBD Profile, Oral Convenience, and Upcoming ABTECT & ENHANCE-CD Data Catalysts
1M ago
ABVX
Obefazimod: Favorable Risk‑Reward on Strong UC Efficacy, Emerging Crohn’s Opportunity, and Undervalued Commercial Upside
Premium
Ratings
Obefazimod: Favorable Risk‑Reward on Strong UC Efficacy, Emerging Crohn’s Opportunity, and Undervalued Commercial Upside
1M ago
ABVX
Abivax SA: Strengthened Outlook for Obefazimod in IBD Drives Higher Target Price and Buy Rating
Premium
Ratings
Abivax SA: Strengthened Outlook for Obefazimod in IBD Drives Higher Target Price and Buy Rating
3M ago
ABVX
0RA9 Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
0RA9 Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
Abivax SA: Buy Rating Affirmed Amid Promising Phase 3 Data and Strategic Growth Prospects
Premium
Ratings
Abivax SA: Buy Rating Affirmed Amid Promising Phase 3 Data and Strategic Growth Prospects
4M ago
ABVX
Optimistic Buy Rating for Abivax SA: Potential of Obefazimod Amid Safety and Financial Considerations
Premium
Ratings
Optimistic Buy Rating for Abivax SA: Potential of Obefazimod Amid Safety and Financial Considerations
4M ago
ABVX
More DE:2X1 News >

2X1 News on the Web

A Look At Abivax (ENXTPA:ABVX) Valuation After Wider Losses Trial Progress And Index Inclusion
Simply Wall St
Neutral
Is It Time To Reassess Abivax (ENXTPA:ABVX) After The Recent Share Price Pullback
Simply Wall St
Neutral
Abivax SA Sponsored ADR (ABVX) Receives a Rating Update from a Top Analyst
TipRanks News
Neutral
Abivax SA (0RA9) Receives a Rating Update from a Top Analyst
TipRanks News
Bullish
Abivax SA Sponsored ADR (ABVX) Gets a Buy from Guggenheim
TipRanks News
Bullish
ABIVAX (ENXTPA:ABVX) EPS Loss Of €2.10 In Q3 Reinforces Bearish Narratives
Simply Wall St
Neutral
Abivax in no rush for a deal, confident key June trial data can secure better terms for partnerships, CEO tells CNBC
CNBC
Bullish
Abivax price target raised to $148 from $142 at Barclays
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DE:2X1
Sector Average
Media Buzz
This Week4 articles
Weekly Average6.25 articles
News Sentiment
This Week100%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:2X1’s Media Buzz Sentiment?
4 articles about DE:2X1 were published this week. In an average week, 6.25 articles are published.
    What is DE:2X1’s weekly average amount of articles?
    In an average week, 6.25 articles about DE:2X1 are published.
      What is DE:2X1’s News Sentiment?
      100% of articles about DE:2X1 were positive this week, compared to its sector average of 59%.
        General Stocks that are Trending in the News
        0O0FCANCOM SE
        PFIProperty For Industry Limited
        MMEDMiniMed Group, Inc.
        0N8FCEWE Stiftung & Co. KGaA
        AAEVAlbion Enterprise VCT
        Showing the stocks with the most bullish news sentiment over the past week